Michelle D. Van Den Beukel

Leiden, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

DuoHexaBody-CD37 induces direct cytotoxic signaling in diffuse large B-cell lymphoma.

DuoHexaBody-CD37 induces direct cytotoxic signaling in diffuse large B-cell lymphoma.

Journal: eLife

Published: July 20, 2026

Post-translationally modified proteins bind and activate complement with implications for cellular uptake and autoantibody formation.

Post-translationally modified proteins bind and activate complement with implications for cellular uptake and autoantibody formation.

Journal: Journal of autoimmunity

Published: January 17, 2025

Commentary: Commentary: Antibodies against multiple post-translationally modified proteins aid in diagnosis of autoimmune hepatitis and associate with complete biochemical response to treatment.

Commentary: Commentary: Antibodies against multiple post-translationally modified proteins aid in diagnosis of autoimmune hepatitis and associate with complete biochemical response to treatment.

Journal: Frontiers in medicine

Published: September 19, 2023

Antibodies against advanced glycation end-products and malondialdehyde-acetaldehyde adducts identify a new specific subgroup of hitherto patients with seronegative arthritis with a distinct clinical phenotype and an HLA class II association.

Antibodies against advanced glycation end-products and malondialdehyde-acetaldehyde adducts identify a new specific subgroup of hitherto patients with seronegative arthritis with a distinct clinical phenotype and an HLA class II association.

Journal: RMD open

Published: July 07, 2023

Type 17-specific immune pathways are active in early spondyloarthritis.

Type 17-specific immune pathways are active in early spondyloarthritis.

Journal: RMD open

Published: May 19, 2023

Antibodies against multiple post-translationally modified proteins aid in diagnosis of autoimmune hepatitis and associate with complete biochemical response to treatment.

Antibodies against multiple post-translationally modified proteins aid in diagnosis of autoimmune hepatitis and associate with complete biochemical response to treatment.

Journal: Frontiers in medicine

Published: March 28, 2023

Autoantibodies against specific post-translationally modified proteins are present in patients with lupus and associate with major neuropsychiatric manifestations.

Autoantibodies against specific post-translationally modified proteins are present in patients with lupus and associate with major neuropsychiatric manifestations.

Journal: RMD open

Published: November 04, 2021

Naturally produced type I IFNs enhance human myeloid dendritic cell maturation and IL-12p70 production and mediate elevated effector functions in innate and adaptive immune cells.

Naturally produced type I IFNs enhance human myeloid dendritic cell maturation and IL-12p70 production and mediate elevated effector functions in innate and adaptive immune cells.

Journal: Cancer immunology, immunotherapy : CII

Published: October 23, 2017

Showing 1-8 of 8

Last Updated: 09/26/2026